Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Gene therapy for cancer treatment: past, present and future.

Cross D, Burmester JK.

Clin Med Res. 2006 Sep;4(3):218-27. Review.

2.

Viral-mediated gene transfer for cancer treatment.

Wilson DR.

Curr Pharm Biotechnol. 2002 Jun;3(2):151-64. Review.

PMID:
12022258
3.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
4.

Adenovirus-mediated cancer gene therapy and virotherapy (Review).

Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML, Naomoto Y.

Int J Mol Med. 2010 Jan;25(1):3-10. Review.

PMID:
19956895
5.

Adenoviral strategies for the gene therapy of cancer.

Relph KL, Harrington KJ, Pandha H.

Semin Oncol. 2005 Dec;32(6):573-82. Review.

PMID:
16338423
6.

Gene therapy progress and prospects cancer: oncolytic viruses.

Liu TC, Kirn D.

Gene Ther. 2008 Jun;15(12):877-84. doi: 10.1038/gt.2008.72. Epub 2008 Apr 17. Review.

PMID:
18418413
7.

Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.

Sinkovics JG, Horvath JC.

Arch Immunol Ther Exp (Warsz). 2008 Dec;56 Suppl 1:3s-59s. doi: 10.1007/s00005-008-0047-9. Epub 2008 Dec 23. Review.

PMID:
19104757
8.

Cancer gene therapy using adeno-associated virus vectors.

Park K, Kim WJ, Cho YH, Lee YI, Lee H, Jeong S, Cho ES, Chang SI, Moon SK, Kang BS, Kim YJ, Cho SH.

Front Biosci. 2008 Jan 1;13:2653-9. Review.

PMID:
17981740
9.

The current status of adenovirus-based cancer gene therapy.

Shirakawa T.

Mol Cells. 2008 Jun 30;25(4):462-6. Epub 2008 May 6. Review.

10.

Targeted gene therapy for ovarian cancer.

Rocconi RP, Numnum TM, Stoff-Khalili M, Makhija S, Alvarez RD, Curiel DT.

Curr Gene Ther. 2005 Dec;5(6):643-53. Review.

PMID:
16457653
11.

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress.

Liu TC, Galanis E, Kirn D.

Nat Clin Pract Oncol. 2007 Feb;4(2):101-17. Review.

PMID:
17259931
12.

Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies.

Ohlfest JR, Freese AB, Largaespada DA.

Curr Gene Ther. 2005 Dec;5(6):629-41. Review.

PMID:
16457652
13.

Gene-modified bone marrow cell therapy for prostate cancer.

Wang H, Thompson TC.

Gene Ther. 2008 May;15(10):787-96. doi: 10.1038/gt.2008.37. Epub 2008 Apr 3. Review.

PMID:
18385769
14.

Gene therapy for pancreatic cancer.

Tseng JF, Mulligan RC.

Surg Oncol Clin N Am. 2002 Jul;11(3):537-69. Review.

PMID:
12487056
15.

Prostate cancer gene therapy.

Steiner MS, Gingrich JR, Chauhan RD.

Surg Oncol Clin N Am. 2002 Jul;11(3):607-20. Review.

PMID:
12487058
16.

Update on gene therapy approaches for cancer.

Wierdl M, Potter PM.

Curr Hematol Rep. 2005 Jul;4(4):294-9. Review.

PMID:
16009044
17.

Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.

Shen RN, Lu L, Kaiser HE, Broxmeyer HE.

In Vivo. 1994 Nov-Dec;8(5):643-52. Review.

PMID:
7727711
18.

Viral vectors in cancer immunotherapy: which vector for which strategy?

Collins SA, Guinn BA, Harrison PT, Scallan MF, O'Sullivan GC, Tangney M.

Curr Gene Ther. 2008 Apr;8(2):66-78. Review.

PMID:
18393828
19.

Gene therapy for cancer: from the laboratory to the patient.

Kouraklis G.

Dig Dis Sci. 2000 Jun;45(6):1045-52. Review.

PMID:
10877214
20.

New strategies for cancer gene therapy: progress and opportunities.

Cao S, Cripps A, Wei MQ.

Clin Exp Pharmacol Physiol. 2010 Jan;37(1):108-14. doi: 10.1111/j.1440-1681.2009.05268.x. Epub 2009 Aug 4. Review.

PMID:
19671071
Items per page

Supplemental Content

Write to the Help Desk